Chris Hurt
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Gastric Cancer Management and Outcomes 25
- Lung Cancer Diagnosis and Treatment 13
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Somnath MukherjeeGareth GriffithsJohn StaffurthTim MaughanT. CrosbyStephen FalkJohn BridgewaterRuby Ray
- Journals
- Journal of Clinical Oncology (14 papers)British Journal of Cancer (11 papers)Radiotherapy and Oncology (6 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)Clinical Oncology (6 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Chris Hurt
112 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 140
- Otorhinolaryngology 244
- Oncology 855
- Pulmonary and Respiratory Medicine 976
- Surgery 1.1k
- Radiation 166
Countries citing papers authored by Chris Hurt
This map shows the geographic impact of Chris Hurt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Hurt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Hurt more than expected).
Fields of papers citing papers by Chris Hurt
This network shows the impact of papers produced by Chris Hurt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Hurt. The network helps show where Chris Hurt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chris Hurt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 20 | |
| 5 | 2021 | 3 | |
| 6 | 2021 | 26 | |
| 7 | High circulating CCL5 is associated with poor prognosis in locally advanced pancreatic cancer (LAPC): Biomarker analysis from the randomized phase II SCALOP trial | 2019 | 1 |
| 8 | 2019 | 7 | |
| 9 | 2018 | 9 | |
| 10 | 2018 | 40 | |
| 11 | 2016 | 23 | |
| 12 | Weekly Outlook: Beef Herd Expanding Quickly, But Will It Continue? | 2015 | 2 |
| 13 | 2015 | 3 | |
| 14 | 2014 | 9 | |
| 15 | 2013 | 272 | |
| 16 | 2013 | 113 | |
| 17 | Marketing of Agricultural Products (10th Edition) | 2007 | 2 |
| 18 | LISA - a web-based trial management and decision support system for childhood acute lymphoblastic leukaemia | 2005 | 2 |
| 19 | Computerised Advice on Drug Dosage Decisions in Childhood Leukaemia: a Method and a Safety Strategy | 2003 | 1 |
| 20 | LISA: A Clinical Information and Decision Support System for Childhood Acute Lymphoblastic Leukaemia | 2002 | 8 |
About Chris Hurt
Chris Hurt is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology, Oncology, Surgery and Radiation, having authored 119 papers that have together received 2.7k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (34 papers), Gastric Cancer Management and Outcomes (25 papers), Pancreatic and Hepatic Oncology Research (22 papers), Lung Cancer Diagnosis and Treatment (13 papers), Radiomics and Machine Learning in Medical Imaging (11 papers), Esophageal and GI Pathology (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Otorhinolaryngology (244 citations), Oncology (855 citations), Pulmonary and Respiratory Medicine (976 citations), Surgery (1.1k citations) and Radiation (166 citations). Chris Hurt has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Somnath Mukherjee, Gareth Griffiths, John Staffurth, Tim Maughan, T. Crosby, Stephen Falk, John Bridgewater, Ruby Ray, Tom Crosby and Rajarshi Roy. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.